2-101295050-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173647.4(RNF149):c.592G>A(p.Gly198Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,614,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173647.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RNF149 | NM_173647.4 | c.592G>A | p.Gly198Ser | missense_variant | 2/7 | ENST00000295317.4 | NP_775918.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RNF149 | ENST00000295317.4 | c.592G>A | p.Gly198Ser | missense_variant | 2/7 | 1 | NM_173647.4 | ENSP00000295317.3 | ||
RNF149 | ENST00000424632.5 | n.592G>A | non_coding_transcript_exon_variant | 2/8 | 2 | ENSP00000399090.1 |
Frequencies
GnomAD3 genomes AF: 0.000270 AC: 41AN: 152084Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251484Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135914
GnomAD4 exome AF: 0.0000513 AC: 75AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000509 AC XY: 37AN XY: 727248
GnomAD4 genome AF: 0.000269 AC: 41AN: 152202Hom.: 0 Cov.: 31 AF XY: 0.000417 AC XY: 31AN XY: 74420
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2024 | The c.592G>A (p.G198S) alteration is located in exon 2 (coding exon 2) of the RNF149 gene. This alteration results from a G to A substitution at nucleotide position 592, causing the glycine (G) at amino acid position 198 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at